Clonidine HCL ER 0.1 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5X01
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,434
Award facts
- Contract value 100% obligated
- $26,434.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count) under a firm fixed-price contract with a ceiling value of $26,434.12. The delivery order, awarded on January 9, 2026, has an ultimate completion date of January 12, 2026, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Clonidine is a centrally acting alpha-2 adrenergic agonist commonly used in military and veteran healthcare settings for hypertension and other indications, making it a critical pharmaceutical commodity for federal medical supply chains.
This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This single-award IDC serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen's consistent performance under this contract vehicle and its demonstrated capability to meet federal procurement requirements through open competition position it as a key pharmaceutical distributor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5X01?
SPE2DR26F5X01 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F5X01 worth?
The government has obligated $26,434 on SPE2DR26F5X01.
Is contract SPE2DR26F5X01 an order under another contract?
Yes. SPE2DR26F5X01 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5X01 competed?
The extent of competition for SPE2DR26F5X01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award